Clinical Trial Update: Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating radiotherapy plus chemotherapy as neoadjuvant treatment for resectable and borderline resectable pancreatic cancer; the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Virginia | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN